Pirayesh Elahe, Amoui Mahasti, Assadi Majid
Department of Nuclear Medicine, Shohada e Tajrish Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; and.
J Nucl Med Technol. 2014 Mar;42(1):77-8. doi: 10.2967/jnmt.113.131581. Epub 2014 Jan 30.
The diagnostic usefulness of somatostatin receptor scintigraphy in the localization of tumors has been evaluated in several studies. Here, we present the case of a patient with a subserosal myoma diagnosed by (99m)Tc-labeled octreotide acetate scintigraphy. Oval and ring-shaped areas of hyperactivity in the pelvis were confirmed on MR imaging to be the uterus and a subserosal myoma. The presented case indicates that somatostatin receptors may be present in the uterus and in leiomyomas, especially in young women, and demonstrates that somatostatin may be a promising therapy for treatment of myoma. The case also demonstrates that subserosal myoma or dislocation of the uterus can result in a false-positive diagnosis, highlighting the importance of correlative imaging for accurate interpretation of the study.
多项研究评估了生长抑素受体闪烁扫描术在肿瘤定位中的诊断价值。在此,我们报告一例通过(99m)锝标记的醋酸奥曲肽闪烁扫描术诊断为浆膜下肌瘤的患者病例。盆腔内椭圆形和环形的高活性区域在磁共振成像上被确认为子宫和一个浆膜下肌瘤。该病例表明生长抑素受体可能存在于子宫和平滑肌瘤中,尤其是在年轻女性中,并且证明生长抑素可能是治疗肌瘤的一种有前景的疗法。该病例还表明浆膜下肌瘤或子宫移位可导致假阳性诊断,突出了相关成像对于准确解读该检查的重要性。